These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18196351)

  • 41. Determinants of symptoms in gastroesophageal reflux disease: nonerosive reflux disease, symptomatic, and silent erosive reflux disease.
    Choi JY; Jung HK; Song EM; Shim KN; Jung SA
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):764-71. PubMed ID: 23459104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diet, lifestyle and gender in gastro-esophageal reflux disease.
    Dore MP; Maragkoudakis E; Fraley K; Pedroni A; Tadeu V; Realdi G; Graham DY; Delitala G; Malaty HM
    Dig Dis Sci; 2008 Aug; 53(8):2027-32. PubMed ID: 18030622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients.
    Ortiz V; Ponce M; Fernández A; Martínez B; Ponce JL; Garrigues V; Ponce J
    Obesity (Silver Spring); 2006 Apr; 14(4):696-700. PubMed ID: 16741272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
    Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
    Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey.
    Nouraie M; Razjouyan H; Assady M; Malekzadeh R; Nasseri-Moghaddam S
    Arch Iran Med; 2007 Jul; 10(3):289-94. PubMed ID: 17604463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of gastro-oesophageal reflux disease in Spain and associated factors.
    Ponce J; Vegazo O; Beltrán B; Jiménez J; Zapardiel J; Calle D; Piqué JM;
    Aliment Pharmacol Ther; 2006 Jan; 23(1):175-84. PubMed ID: 16393295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia.
    Velanovich V; Hollingsworth J; Suresh P; Ben-Menachem T
    Dig Surg; 2002; 19(5):349-53. PubMed ID: 12435904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased risk for microscopic colitis and inflammatory bowel disease among patients with reflux disease.
    Sonnenberg A; Turner KO; Genta RM
    Colorectal Dis; 2018 Sep; 20(9):813-820. PubMed ID: 29603881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gastroesophageal reflux in the French general population: national survey of 8000 adults].
    Bretagne JF; Richard-Molard B; Honnorat C; Caekaert A; Barthélemy P
    Presse Med; 2006 Jan; 35(1 Pt 1):23-31. PubMed ID: 16462660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of gastroesophageal reflux in a Tunisian primary care population determined by patient interview.
    Ben Chaabane N; El Jeridi N; Ben Salem K; Hellara O; Loghmari H; Melki W; Bdioui F; Safer L; Soltani M; Saffar H
    Dis Esophagus; 2012 Jan; 25(1):4-9. PubMed ID: 21595777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and clinical predictors of LPR among patients diagnosed with GERD according to the reflux symptom index questionnaire.
    Mosli M; Alkhathlan B; Abumohssin A; Merdad M; Alherabi A; Marglani O; Jawa H; Alkhatib T; Marzouki HZ
    Saudi J Gastroenterol; 2018; 24(4):236-241. PubMed ID: 29652032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Features of gastroesophageal reflux disease in women.
    Lin M; Gerson LB; Lascar R; Davila M; Triadafilopoulos G
    Am J Gastroenterol; 2004 Aug; 99(8):1442-7. PubMed ID: 15307857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal metaplasia in the distal esophagus and correlation with symptoms of gastroesophageal reflux disease.
    Dietz J; Meurer L; Maffazzoni DR; Furtado AD; Prolla JC
    Dis Esophagus; 2003; 16(1):29-32. PubMed ID: 12581251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and risk factors for gastro-esophageal reflux disease in the North-Eastern part of Bangladesh.
    Shaha M; Perveen I; Alamgir MJ; Masud MH; Rahman MH
    Bangladesh Med Res Counc Bull; 2012 Dec; 38(3):108-13. PubMed ID: 23540187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea.
    Cho YS; Choi MG; Jeong JJ; Chung WC; Lee IS; Kim SW; Han SW; Choi KY; Chung IS
    Am J Gastroenterol; 2005 Apr; 100(4):747-53. PubMed ID: 15784014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
    Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of gastroesophageal reflux disease on daily life: the Systematic Investigation of Gastrointestinal Diseases in China (SILC) epidemiological study.
    Wang R; Zou D; Ma X; Zhao Y; Yan X; Yan H; Fang J; Yin P; Kang X; Li Q; Dent J; Sung JJ; Halling K; Johansson S; Liu W; He J
    Health Qual Life Outcomes; 2010 Nov; 8():128. PubMed ID: 21062502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.